Odaily News OKX market data shows that SOL fell below 150 USDT and is now at 149.97 USDT, with a 24-hour drop of 0.19%. (This newsletter is generated by AI)

Odaily News Bitget market data shows that CFX rose by more than 8% in a short period of time and is now at 0.0769 USDT. Earlier news, Leading Pharmaceutical Biotechnology planned to acquire all the shares of Conflux to expand into the field of blockchain technology.

Odaily News Matrixport released today's chart, saying that Bitcoin usually moves steadily in the summer, but July has repeatedly broken the rules. In the past ten years, it has closed higher seven times, with an average increase of 9.1%; even in the years of decline, the decline was only in the single digit. In the five years of increase, there was a strong double-digit rebound. As July approaches, the market's bullish sentiment is gradually heating up. The historical trend is re-enacted, and the market may usher in a new round of increases and may challenge the $116,000 mark in the next few weeks.

Odaily News Byreal's first Fragmetric Reset Launch has ended, with a target of 2199.0112 bbSOL and an actual oversubscription of 49587.8 bbSOL, worth more than 8.18 million USD. The lowest price level was oversubscribed by 4406.96%. Whitelisted users who participated in the event can claim FRAG tokens and get a refund at 15:30 Beijing time.

Odaily News Bitget market data shows that HFT (Hashflow) rose above 0.13 USDT and is currently trading at 0.1374 USDT, with a 24-hour increase of 94.89%.

Odaily News Hong Kong-listed company Pioneer Pharmaceutical Biotechnology Co., Ltd. (00399) announced the signing of a memorandum of understanding, planning to acquire all the equity of the target company, provided that the target company completes the acquisition of Conflux blockchain-related assets. The price of the acquisition will be paid in cash, company shares or convertible bonds, and the specific amount will be determined in the formal agreement. The memorandum of understanding is valid for 12 months, during which the seller shall not negotiate or trade with other parties regarding the equity of the target company. Pioneer Pharmaceuticals hopes to expand its business into the field of blockchain technology through this acquisition, diversify its business and find new profit growth points. However, the transaction still needs to be implemented after the signing of a formal agreement. The relevant announcement will be issued in due course in accordance with the listing rules, and shareholders and investors need to act with caution.